1. Methylation multiplicity and its clinical values in cancer
   Xiaofeng Dai et al, 2021, Expert Rev. Mol. Med. CrossRef
2. The m6A RNA methylation regulates oncogenic signaling pathways driving cell malignant transformation and carcinogenesis
   Mohammad Burhan Uddin et al, 2021, Mol Cancer CrossRef
3. The Biological Function, Mechanism, and Clinical Significance of m6A RNA Modifications in Head and Neck Carcinoma: A Systematic Review
   Feng-Yang Jing et al, 2021, Front. Cell Dev. Biol. CrossRef
4. null
   Mohammad Burhan Uddin et al, 2021 CrossRef
5. m6A-express: uncovering complex and condition-specific m6A regulation of gene expression
   Teng Zhang et al, 2021 CrossRef
6. Inhibiting PP2Acα Promotes the Malignant Phenotype of Gastric Cancer Cells through the ATM/METTL3 Axis
   Zhaoxiang Cheng et al, 2021, BioMed Research International CrossRef
7. Anti-Gastric Cancer Effect of Purified Omphalia lapidescens Protein via Regulating the JAK/STAT3 Signaling Pathway
   Yuqin Xu et al, 2021, Nutrition and Cancer CrossRef
8. Differential STAT gene expressions of Penaeus monodon and Macrobrachium rosenbergii in response to white spot syndrome virus (WSSV) and bacterial infections: Additional insight into genetic variations and transcriptomic highlights
   Tze Chiew Christie Soo et al, 2021, PLoS ONE CrossRef
9. RNA-Binding Protein IGF2BP1 Associated With Prognosis and Immunotherapy Response in Lung Adenocarcinoma
   JinFeng Liu et al, 2022, Front. Genet. CrossRef
10. The N6-methyladenosine:mechanisms, diagnostic value, immunotherapy prospec-ts and challenges in gastric cancer
    Wenzhang Wu et al, 2022, Experimental Cell Research CrossRef
11. Risk Score Prediction Model of Prognosis in GC Patients by Age and Gender Combined With m6A Modification Genes FTO and RBM15
    Limin Yue et al, 2022, Front. Cell Dev. Biol. CrossRef
12. A new risk model based on a 11-m6A-related lncRNA signature for predicting prognosis and monitoring immunotherapy for gastric cancer
    Liangliang Lei et al, 2022, BMC Cancer CrossRef
13. CRISPR/Cas9 application in cancer therapy: a pioneering genome editing tool
    Sadegh Shojaei Baghini et al, 2022, Cell Mol Biol Lett CrossRef
14. N6-Methyladenosine Modification Patterns and Tumor Microenvironment Immune Characteristics Associated With Clinical Prognosis Analysis in Stomach Adenocarcinoma
    Zhang Meijing et al, 2022, Front. Cell Dev. Biol. CrossRef
15. Alternative splicing of METTL3 explains apparently METTL3-independent m6A modifications in mRNA.
    Hui Xian Poh et al, 2022, PLoS Biol CrossRef
16. Methyltransferase-like 3 facilitates lung cancer progression by accelerating m6A methylation-mediated primary miR-663 processing and impeding SOCS6 expression
    Shengshu Li et al, 2022, J Cancer Res Clin Oncol CrossRef
17. Expression profiles of m6A RNA methylation regulators, PD-L1 and immune infiltrates in gastric cancer
    Zhiyuan Xu et al, 2022, Front. Oncol. CrossRef
18. CRISPR/Cas9 as precision and high-throughput genetic engineering tools in gastrointestinal cancer research and therapy
    Sayedeh Azimeh Hosseini et al, 2022, International Journal of Biological Macromolecules CrossRef
19. The regulatory role of N6-methyladenosine RNA modification in gastric cancer: Molecular mechanisms and potential therapeutic targets
    Gaofeng Li et al, 2022, Front. Oncol. CrossRef
20. Dual roles of demethylation in cancer treatment and cardio-function recovery
    Xinuo Li et al, 2023, Redox Biology CrossRef
21. Role of N6-methyladenosine RNA modification in gastric cancer.
    Si-Qi Ding et al, 2023, Cell Death Discov CrossRef
22. METTL3 facilitates stemness properties and tumorigenicity of cancer stem cells in hepatocellular carcinoma through the SOCS3/JAK2/STAT3 signaling pathway
    Jingjing Hu et al, 2023, Cancer Gene Ther CrossRef
23. null
    Michelle Verghese et al, 2023 CrossRef
24. N6-methylation in the development, diagnosis, and treatment of gastric cancer
    Jiaxin Wang et al, 2024 CrossRef
25. RETRACTED: Optimizing sgRNA to Improve CRISPR/Cas9 Knockout Efficiency: Special Focus on Human and Animal Cell
    Sadegh Shojaei Baghini et al, 2021, Front. Bioeng. Biotechnol. CrossRef
26. The Interplay Between Helicobacter pylori and Suppressors of Cytokine Signaling (SOCS) Molecules in the Development of Gastric Cancer and Induction of Immune Response
    Abdollah Jafarzadeh et al, 2024, Helicobacter CrossRef
27. The regulatory mechanism of m6A modification in gastric cancer
    Si Wu et al, 2024, Discov Onc CrossRef
28. The evolving process of ferroptosis in thyroid cancer: Novel mechanisms and opportunities.
    Lin Yin et al, 2024, J Cell Mol Med CrossRef
29. Methyltransferase METTL3 regulates neuropathic pain through m6A methylation modification of SOCS1
    Liping Wu et al, 2024, Neuropharmacology CrossRef
30. Trends and frontiers of RNA methylation in cancer over the past 10 years: a bibliometric and visual analysis
    Bo-Na Liu et al, 2024, Front. Genet. CrossRef
31. Unraveling the landscape of m6A RNA methylation in wound healing and scars
    Qi Zhang et al, 2024, Cell Death Discov. CrossRef
32. Current insights on m6A RNA modification in acute leukemia: therapeutic targets and future prospects
    Parminder Kaur et al, 2024, Front. Oncol. CrossRef
33. METTL3 as a potential therapeutic target in gastric cancer
    Zhefei Yu et al, 2024, Front. Oncol. CrossRef
34. Research Progress on N6-Methyladenosine Modification in Angiogenesis, Vasculogenic Mimicry, and Therapeutic Implications in Breast Cancer
    Jiachen Weng et al, 2024, Progress in Biophysics and Molecular Biology CrossRef
35. Gold Nanoparticle Inhibits the Tumor‐Associated Macrophage M2 Polarization by Inhibiting m6A Methylation‐Dependent ATG5/Autophagy in Prostate Cancer
    Yuanyuan Hao et al, 2025, Analytical Cellular Pathology CrossRef